Local Institution

Reutlingen 72764

0 studies enrolling now · 1 studies all time

What they study most

Cancer of the Stomach, Gastric Cancer, Gastroesophageal Junction, Stomach Cancer

Studies at this site

• An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma — Withdrawn before enrolling